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Abstract 
Supply of safe vaccines is very important and appropriate procedures, monitoring and logistics systems need to 
be put in place to ensure safety. The pharmaceutical supply chain have various global regulatory requirements to 
be met during transport ,storage, packaging and  handling environmentally sensitive products like biologicals, 
vaccines and some medicines. This is to ensure that quality and efficacy of cold chain products is not 
compromised along the supply chain. Global players have regulations and guidelines that address product 
integrity and safety during the entire supply chain. It was therefore of importance to identify how Pharmaceutical 
distributors in Nairobi County have developed their cold chain supply systems and how it is able to maintain 
cold chain for temperature-sensitive pharmaceuticals considering the challenges of; Transport systems, storage 
facilities, packaging, technical capacity, unreliable electricity supply, weak validation systems, probable poor 
monitoring of cold chain supply systems. The main objective of the study was to establish the influence of 
supply chain logistics in supply of safe pharmaceutical cold chain products in Pharmaceutical distributor firms in 
Nairobi County while the specific objectives were to determine how storage conditions in pharmaceutical 
distributors in Nairobi influences safety of vaccines; to determine the influence of transport systems on the safety 
of vaccine; to evaluate the influence of Packaging on the safety of vaccines and finally establish the extent to 
which technical capacity influence safety of Vaccines in pharmaceutical distributors in Nairobi. Descriptive 
survey design was considered because it is non-experimental and studies the relationship between non-
manipulated variables in a natural setting. The study was carried out in five major pharmaceutical firms out of 16 
registered cold chain pharmaceutical distributors in Nairobi County. A sample size of 67 participants was 
selected out of a population of 211 staff from different firms consisting of the automatically included 5 supply 
chain managers and 62 employees from procurement and stores department. The data was collected by use of 
self-administered questionnaires to the sampled respondents by a drop and pick method. The questionnaires were 
coded and data analyzed using Statistical Package for Social Science (SPSS V-17).Correlation analysis was done 
to determine the relationship between the dependent and independent variables whereby it was found that 
technical capacity and storage conditions have the greatest relationship and influence to the safety of vaccines. 
The findings were presented through figures, tables, and graphs. 
Keywords: Cold chain, logistics, Pharmaceuticals, Safety 
 
1. INTRODUCTION 
In as much as globalization has made the world a global village through phone calls, emails, social networking, 
e-conferencing and videos that are easily transmitted in seconds, this has not penetrated other areas such as 
pharmaceuticals where goods have to be physically moved. Ames, (2006) emphasizes that cold chain supply 
requires a lot of logistical coordination and this can only be made possible by cold chain technology which has 
various impacts on timely delivery and quality of the pharmaceutical cold chain products and hence their 
potency and safety for administration to patients. 
At the global perspective, Estrada, (2008) defines procurement as the acquisition of goods, services or 
works from an outside external source at the best possible cost to meet the needs of the purchaser in terms of 
quality and quantity, time, and location. The cold chain is the process of maintaining medication such as insulin, 
vaccines; biologicals within recommended temperatures mostly between 2ºC to 8ºC throughout the supply chain 
(Bishara, 2006). In the health sector pharmaceutical cold chain is concerned with the transportation, storage, and 
handling of pharmaceutical products in a safe environment from the manufacturer to the end user. Temperatures 
outside recommended temperature ranges may reduce potency leading to lack of desired response e.g. reduced 
immunity. Control of storage and transportation temperature is essential in maintaining the quality of medicines 
and in helping to protect patients from sub-standard or ineffective medicines that may result from inadequate 
control (Blake, 2008). Lack of awareness by distributors in the control of storage and transportation temperatures 
can have a major impact on product quality. 
World Health Organization (WHO) has noted that twenty five percent of all vaccine products reach 
their destination in a degraded state. This according to The Medicines and Healthcare Products Regulatory 
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Agency is due to temperature rises above desired parameters thereby contributing forty three percent of reported 
non-compliant cases. Worldwide vaccine-preventable diseases are responsible for about twenty five percent of 
the ten million deaths occurring annually for children under five years of age. Global warming makes 
temperature control issues a growing challenge in the cold chain supply (Bishara, 2007).  
Bishara, (2007) states that according to Medicines and Healthcare Products Regulatory Authority 
(MHRA) of the United Kingdom, thirty two percent of all critical and major deficiencies recorded by MHRA’s 
Good Distribution Practice (GDP) inspectors during 2005/2006 related to the control and monitoring of storage 
and transportation temperatures. Comparatively, forty three percent critical and major deficiencies were recorded 
in 2004/2005 respectively. In view of this, many countries such as Canada, Ireland, Australia, Singapore, South 
Korea, and European Union have issued regulations and specific guidelines that address product integrity during 
transportation of cold chain medicines and hence the significant reduction in deficiencies.  
At the continental level, Forcinio and Wright, (2005) has noted that in lower-income countries in 
Africa, efforts to have an efficient cold chain supply process are often hampered by poor health delivery systems, 
low political commitment, low levels of investment, poorly maintained cold chains, lack of human resources, 
poor effective disease surveillance and reporting systems which are key components of the procurement and 
logistics process. 
A survey by Agyekum (2012), conducted in Ghana, Kenya and Uganda  indicates that an average of 
sixteen percent of the sampled facilities were not compliant to the guidelines laid out by regulatory authorities 
and fifty percent of these facilities had temperatures 4°c or more outside the recommended temperatures. For 
example only four per cent of facilities stored vaccines in cold boxes, while the remainder used refrigerators and 
storage outside the recommended range. Though significant variation was observed between the countries; 
twenty six percent, sixteen percent, and eight percent for Ghana, Kenya, and Uganda, respectively there remains 
significant room to improve cold chain supply in these countries among others in Africa ( Burger, Kopf, Yoong, 
& Sood. 2012) 
In a comparison of African countries based on their cold supply chains, it was found that Ghana had 
developed its cold chain supply systems and now it is able to maintain cold chain for temperature-sensitive items 
than Kenya and Uganda in spite of facing similar challenges. According to Agyekum (2012), this was because 
Ghana’s regulatory Authorities have been able to develop validation methods and guidelines for the cold chain 
delivery system, with the goal of providing temperature assurance during the manufacturing, storage, shipping 
and delivery of cold chain items ( Burger, Kopf,  Yoong, & Sood. 2012) 
The Kenyan government and several international donors that provide vaccines which are the main 
pharmaceutical cold chain products for the Kenya Expanded Programme for Immunisation (KEPI). These 
pharmaceutical cold chain products are managed and distributed through the KEPI vertical program and are 
stored at the central level in the KEPI cold store. KEPI has a strong information system that includes good stock 
control practices. This facilitates recording of vital information on vaccines on reception, during storage and 
when they are leaving the store for distribution.  
However, it is not only KEPI that imports and distributes medical products and vaccines in Kenya as 
there are other players in the field. Kalunda, Nduku, and  Kabiru (2012) reveal that a pharmaceutical company is 
a commercial business licensed to research, develop, market and/or distribute drugs, most commonly in the 
context of healthcare. The pharmaceutical industry consists of three segments namely the manufacturers, 
distributors and retailers (Export Processing Zones Authority– Kenya, 2005).. The key players in the industry in 
Kenya include multinational corporations (MNC’s) like GlaxoSmithKline, Bayer, Sanofi Aventis, and Pfizer 
while key local establishments include Dawa Pharmaceuticals Ltd, Cosmos Pharmaceuticals. They deal in brand 
and/or generic medications. They support the country’s health sector, which is estimated to have about 8,006 
health institutions countrywide (Kenya National Bureau of Statistics (KNBS), 2012).  
Most of these players that are predominantly, privately owned firms in engaging in pharmaceutical 
products that require cold chain sometimes use equipment that are not compatible with WHO–UNICEF product 
information sheets (PIS) and cannot ensure the storage temperatures required for different types of 
pharmaceutical cold chain products. Ayaya, Liechty, Conway, Kamau, and Esamai, (2007) reasons that this may 
lead to poor maintenance and possible malfunction which may put vaccines at risk of exposure to unacceptable 
temperatures.  The factors leading to this supply of not very safe pharmaceutical cold chain items has not been 
well identified and this research therefore seeks to establish these factors (Ministry of Health (MOH), 2004). 
In Kenya the cold chain supply has generally been neglected in regard to the establishment, 
development, maintenance and control of the activities involved especially in the private sector which really 
supports the health sector mainly because the cold chain supply process involves multiple parties, high risks and 
high financial investments .When there is an equipment or management failure at the primary level, large 
quantities of cold chain products may be destroyed in a matter of a few hours (Kamau, &  Mukui.  2005).  
Most of these players require a cold chain logistic in order to ensure proper handling, temperature 
control and monitoring for safety and quality in each stage of the supply chain lest the very functions of the 
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medicinal products and vaccines as stated by Bishara, (2006) be rendered futile. According to PPB (2013) there 
are 1332 registered pharmaceutical companies and chemists in Kenya, with 50 percent of them in Nairobi and 
only 10 percent are involved in cold chain supply and only 10 percent of those involved in cold chain supply are 
involved in importation and distribution to the other pharmaceuticals, the hospitals and health facilities. 
 
1.1 STATEMENT OF THE PROBLEM 
The importance of the cold chain is crystal clear to the government and key stakeholders within the industry 
based on their impact on health, very little effort is done to control the effects of supply chain logistics such as 
transport, storage ,  packaging, technical capacity and many other sensitive activities that help keep such 
products safe and in good quality. This is confirmed by Bishara, (2007) who asserts that pharmaceutical cold 
chain items like vaccines are particularly sensitive materials which, if not manufactured and shipped under 
stringent controls, can become ineffective or even hazardous to the consumer due to reduced potency.  
Kamau and Mukui ,(2005), noted that lack of awareness by distributors in the control of storage and 
transportation temperatures can have a major impact on product quality by non-observance of the cold chain or 
inefficiency in its monitoring mechanisms. This may affect the products' therapeutic properties and consequently 
generate deficiency quality risks such as loss of therapeutic effects and intoxication with dire effects on the 
health of the users.  
Storage conditions and facilities are not upto standard and there lacks a fleet of specialised transport 
systems to ensure no cold chain breaks during transport by doing proper monitoring of tempretures. Packaging 
materials used are questionable in maintain the correct tempretures and conditions to ensure safety of vaccines. 
Most firms also seem not to be technically capable to handle cold chain effectively to ensure their safety. 
Proper packaging  Regulatory and compliance issues relating to transportation, storage, packaging and 
technical compliance , influences the safety cold chain items to the user level are critical in this process to avoid 
degradation (Blake, 2008) This is why this study is timely in analysing the influence of cold chain supply 
logistics on supply of safe cold chain products. 
 
1.2 OBJECTIVES  
General Objective 
The general objective of this study was to establish the influence of cold chain supply logistics on safety of 
vaccines in pharmaceutical distributors in Nairobi. 
Specific Objectives 
1 To determine how storage conditions in pharmaceutical distributors in Nairobi influences safety of 
vaccines. 
2 To determine the influence of transport systems on the safety of vaccines in pharmaceutical distributors 
in Nairobi 
3 To evaluate the influence of Packaging in pharmaceutical distributors in Nairobi on the safety of 
vaccines. 
4 To establish the extent to which technical capacity in pharmaceutical distributors in Nairobi influence 
safety of Vaccines 
Research Questions  
The research questions of this study were: 
1. How does storage conditions in pharmaceutical distributors in Nairobi influence safety of vaccines? 
  
2. How do transport systems of vaccines in pharmaceutical distributors in Nairobi influence their safety? 
3. How does packaging of vaccines within pharmaceutical distributors in Nairobi influence their safety? 
4. How  does technical capability of pharmaceutical distributors in Nairobi influence safety of Vaccines 
 
2. LITERATURE REVIEW 
The study was grounded on three theories mainly;Agency theory,Flat earth theory and the 3-dimensional theory. 
 
2.1 Agency Theory  
Agency theory explains relationship between two parties, mainly an agent and a principal whereby the principal 
delegates to the agent his powers to act on behalf, represent, and carry out transactions with a third party. In such 
relationships, there is often a tendency of power abuse by agents and problems arise due to agency inefficiency. 
Agency theory helps understand the conditions under which a supply chain member is likely to attempt to exploit 
other members.  
The theory also guides in an investigation of the effect of such opportunism on supply chain 
effectiveness and how it can be prevented or minimized. The agency theory was promoted with seminal works of 
Max Weber (Beckert, and Zafirovski, 2006), was mostly concerned with the conflict between political master 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.5, No.9, 2015 
 
94 
and state officials. This view was built on the foundation of the neoclassical view of organization-that views the 
organization as black boxes of operations, where the “relationship between performance and incentives “was 
over looked (Beckert, and Zafirovski, 2006). 
New institutionalism view of organization opened the black box of organizational operations and 
paved way for contemporary view of the agency theory. In the old institutionalism view, opportunistic behavior 
based on the rational system view was dominant. However, the new institutionalism view of the organizations, 
promotes the delegation of responsibilities and operation, through an open system view towards the environment. 
The agency theory – from the classical or neoclassical perspectives provides contributions to the understanding 
of supply chain management. Agency theory has been applied to various activities associated with supply chain 
management including, outsourcing (Logan, 2000; Loebbecke & Huyskens, 2009,) sourcing (Shook, Adams, 
Ketchen & Craighead 2009), and supply chain collaboration (Kwon & Suh, 2004). Agency theory is useful in the 
study of cold supply chain in the pharmaceutical industry as it informs why firms opt to use distributors or agent 
to supply products 
 
2.2 Flat Earth Theory 
Friedman, (2007) explains that there are three eras of globalization and ten flatteners which made the world 
smaller, making it easier to communicate and share our knowledge. The first era, called between the years 1492, 
when Columbus set out to discover a new trade route to the New World, and 1800, made the world fall in size 
from large to medium. During this period, the strength of a country was based on the number of horsepower or 
the number of steam engines owned, compared with other countries. The second period between the years 1800 
and 2000 decreased the size of the world, from medium to low. Multinational companies were the integration 
force, and the power was given to a company by the level of innovation in the field of machinery and equipment.  
The third globalisation era began around the year 2000. The first two eras led to globalization at the country 
level and, later, at the company level, this new era favorized reduction to a very small world, flattening the 
playing field and putting the individual in the centre Friedman, (2007). Globalization has been maintained by the 
action of some flattening factors that favoured the levelling of the World and the emergence of some 
opportunities that could increase welfare if successfully exploited. 
One common misconception in cold chain supply is that product storage and distribution temperatures 
are the same. The idea that the products’ long-term storage temperature is not the same as the distribution 
temperature is easily forgotten .Cold chain products was be exposed to warmer or colder  conditions as it moves 
downstream the supply chain. Where the vaccines are taken out of the target refrigeration temperature range for 
a short period and later placed back to the proper conditions without compromising the product quality. In the 
pharmaceutical industries, we find that the stability studies are mandatory by health authorities and these studies 
are performed following a strict and standardized method outlined by the International Committee of 
Harmonization (ICH). The Quality Stability group performs these studies and the Regulatory group uses the 
results to establish storage temperature and product shelf life, to file the drug product registrations and to answer 
questions from regulatory bodies however, stability studies are lengthy and expensive and are specific to the 
primary container and the manufacturing site.  
On the other hand, a standardized method to define the distribution temperature is not available and is 
common to find that many companies only perform long-term stability studies and established storage 
temperatures. Companies with only storage temperature have the flat-earth view because they assume that 
distribution temperature must be the same as the storage temperature. This flat-earth view creates many supply 
chain inefficiencies because of the need of extra protection due to the fear of the unknown outside the long term 
stability conditions.  
 
2.3 Three-Dimensional Generic Theory Approach 
Efficient intra and inter organizational information management in cold chain supply has different dimensions 
(Althoff, Ellebrecht, & Petersen, 2005). The technical dimension implies aspects of data distribution and storage, 
the possibilities of data exchange and in general the technology it incorporates. Craig (2007) describes the 
technical dimension as a group which includes mainly visible, tangible, measurable and easy-to-change 
components. 
Organizational structure indicates the performance of different tasks as well as activities, for example 
in cross-functional teams. Van der Vorst, Da Silva, and Trienekens, (2007). understands under this aspect 
management methods, power and leadership structure, risk and reward structure and culture and attitude of the 
involved organizations describe in their techno-managerial approach a technical and an organizational or 
managerial perspective, respectively. Althoff, Ellebrecht and Petersen, (2005) define a third functional 
dimension of functional requirements which determine the information management in a quality and health 
management context. In relation to pharmaceutical cold chain management, mainly the proposed linkage of 
quality related data to other data sets at inspection and decision points may be categorized in this dimension. 
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Safety of cold chain products is influenced by the organisation structure in terms of information sharing, 
technical and functional undertaking of cold chain related processes. 
 
2.4 Conceptual framework  
The conceptual framework illustrates the relationship between the independent variable, and dependent variable. 
The independent variables include; storage conditions, transport systems, packaging and technical capacity 
which was measured, the dependent variable is safe cold chain items, which in this study is vaccines. 
In Kenya very little cold chain medicine is manufactured and hence relies heavily on importation. 
Private suppliers receive their cold chain products from the airport cold room, transport them to wholesale 
storage facilities and distribute to retail pharmacies from their cold storage holding facilities. The Safety of cold 
chain pharmaceuticals/ vaccines is greatly influenced by variations during transport, storage conditions and 
facilities, handling and packaging (Bishara, 2007). 
Members of the pharmaceutical supply chain have various regulatory requirements to meet while 
distributing, storing and handling cold chain products to ensure that the quality and efficacy of the product are 
not compromised along the supply chain. The cold chain system consist of a series of transport and storage links 
which also involve a lot of handling, designed to keep products within an accepted temperature range until it 
reaches the end user. Storage is a critical parameter in maintaining the quality, safety, stability and efficacy of 
cold chain products and must be stored in accordance with the requirements of its marketing authorization 
(Skuce, 2010). 
The operation of the pharmaceutical cold chain management cycle is also affected by some intervening 
factors which are political, legal, and regulatory framework may cause delays reducing on the lead time and 
compromise on product quality and safety, however these intervening factors were not measured in this study. 
 
Figure 2.1: Conceptual Framework 
 
3. RESEARCH METHODOLOGY 
3.1  Research Design 
This study adopted a Descriptive survey design to generate answers to the research questions (Orodho, 2003). 
Descriptive survey design was considered because it is non-experimental and it studies the relationship between 
non-manipulated variables in a natural setting, it also allows the collection of a large amount of data from a 
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sizable population in a highly economical way (Kumar. R. 2005). The data collected was descriptive in nature 
and was used to assess the influence of cold chain supply logistics on the safety of vaccines in Nairobi County. 
This design helps obtain information that describes existing phenomena by asking individuals about their 
perceptions, attitudes, behaviour or values (Mugenda, O. & Mugenda, and A. 2003).  
 
3.2 Population  
Mugenda and  Mugenda,  (2003) defines a population as the full set of cases from which a sample is taken. The 
population in this research study was drawn from Pharmacies and Poison Board registered cold chain 
pharmaceutical distributors in Nairobi County.  
 
3.3 Sampling frame 
The sampling frame for the study was drawn from the registered cold chain pharmaceutical distributors in 
Nairobi County . Mugenda, and Mugenda, (2003) states that a sampling frame is an index of cases from which a 
sample is selected. According to PPB (2013) there are 16 registered cold chain pharmaceutical distributors in 
Nairobi County.  
Table 1: Sampling frame 
Population Size(Firms) Percent Sample %                       Sample   Size  
16   30                                                    5 
The five firms are; Phillips Healthcare, GlaxoSmithKline Kenya, Novartis Limited, Laborex Kenya, and Sanofi 
Aventis. 
 
3.4 Sampling and Sampling Technique 
A sample is a representative of a population according to Mugenda, and Mugenda, (2003).Sampling facilitates 
the study of a relatively smaller number of units compared to the target population and therefore helps obtain 
data that is representative of the whole population. A non-probabilistic sampling technique, specifically 
purposive sampling, was used to select the study region (Nairobi county) .Purposive sampling was appropriate in 
the selection of the Nairobi county region in because it allows for the selection of unique cases that are especially 
informative. Nairobi County being the capital city of Kenya where most of the main distributors are located 
(PPB, 2013). 
Mugenda, and Mugenda, (2003) suggests that a sample size of 384 is representative for a population 
greater than 10,000 when the Z statistic is 1.96 at 95% confidence level. However the target population in this 
case is much less and hence followed Orodho (2005) statement that a sample of thirty percent is representative 
enough for a descriptive study; therefore a representative sample of five  organizations was selected  being thirty 
percent of the sixteen registered cold chain pharmaceutical distributors in Nairobi county involved in distribution 
to the other pharmaceuticals, the hospitals and health facilities .The five firms were selected purposively as firms 
that influence eighty percent of the cold chain supply market in the pharmaceutical sector as they are directly 
involved in the importation of vaccines (PPB, 2013). The five firms are; Phillips Healthcare, GlaxoSmithKline 
Kenya, Novartis Limited, Laborex Kenya, and Sanofi Aventis. 
The target population was stratified into, middle level managers and operational level personnel 
involved in the cold chain. For the middle level managers (departmental heads), there was automatic inclusion 
sampling while for the operational level personnel stratified simple random sampling was used to sample other 
categories of sample size to select 30 percent of the target population based on Orodho (2005) that a sample of 
30 percent is representative enough for a descriptive study based on characteristics such as position and 
experience, among others.  
The targeted population under study comprise of staffs that are involved directly or indirectly in the 
procurement and logistics process of cold chain pharmaceuticals from the selected pharmaceutical distributors. 
The sample size of 67 participants was selected from all the different firms consisting of the automatically 
included 5 supply chain managers and 62 employees from procurement and stores department. 
Table 2: Distribution of sample size 
Staff Category Sampling technique Population Size Percent Sample 
Sample %      Size     
Supply-chain manager Automatic inclusion 5  100             5 
Procurement team Simple random 86   30              26 
Stores-Support staff Simple random  120   30              36 
Total  211                      67 
 
3.5 Instruments  
The main instrument for data collection used was a structured questionnaire. 
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According to Sushil (2010), a questionnaire is a method of survey data collection with a group of printed 
questions which are deliberately designed and structured to gather information from respondents. This study 
used a structured questionnaire with close ended questions standardized in order to allow for easy comparison 
(Mugenda, O. & Mugenda, A.2003). The questionnaires contained relevant questions which were designed with 
the objectives of the study in mind. The questionnaire was issued to all sampled respondents across various 
category spectrum, and explore perceptions and feelings, general experiences, as well as knowledge and general 
information on the subject under study (Mugenda,O. & Mugenda,A.2003). 
 
3.6 Data Collection methods  
The research data was collected from primary sources through questionnaires and secondary data reviewed from 
existing literature, the firms’ records, published material, journals and internet sources. The questionnaires were 
self-administered to the sampled respondents by a drop and pick method. Permission to carry out the research 
and authorization letter was be received from the University prior to administering the questionnaires and the 
researcher also went the sampled organizations for introduction and also seek a written approval to carry out the 
research confidentially for academic purpose only.  
 
3.7  Data analysis and presentation 
The researcher used both descriptive and inferential statistics to analyze data to allow for meaningful description 
data collected using statistics and to compare variables numerically by Correlation analysis. The data collected 
through questionnaires was coded and entered into the Statistical Package for Social Science (SPSS V-17) for 
analysis of quantitative data . Correlation analysis was used to establish the relationship between the independent 
variables which are storage conditions, transport systems, packaging and technical capacity with the dependent 
variable which is safety of cold chain items. The resulting correlation coefficient (R) gave the indication of the 
strength and direction of the relation between the independent and dependent variables where values closest to 
+1 indicate a strong relationship and vice versa. Inferential statistics were used to make inferences about the 
population and a comparison for qualitative data based on literature reviewed and industry standards already 
set.Analyzed data was presented using Tables, graphs and charts . 
 
4. RESEARCH  FINDINGS AND DISCUSSION 
4.1Introduction 
This chapter describes the analysis and methods that were used in order to answer the research questions 
generated from the general objective of the study which  is to establish the influence of cold chain supply 
logistics on safety of vaccines in pharmaceutical distributors in Nairobi. Detailed descriptive statistics such as 
frequencies and graphs and inferential statistic such as exploratory factor analysis, Pearson’s correlation 
coefficient the key research findings are presented.  
Gay and Airasian (2006) states that data analysis is the separation of data and examining data 
separately. Data analysis refers to examination of information collected by ordering and restructuring data from 
the field in order to grasp the overall meaning in relation to the hypothesis, the purpose of which is to illustrate 
the issues by making inferences. 
 
4.2 Response Rate 
An analysis of the respondents who were responsive and non responsive was as illustrated in the table below. 
Table 4.1 Response Rate 
Rating Frequency Response rate % 
Responded 58 87 
Non-response 9 13 
Total 67 100 
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RESPONSE RATE  %  
 
Figure 4.1 .Response Rate 
This was to establish the response rate of the respondents from  Table 4.1, the total number of that 
were administered were 67 and out of them 58 questionnaires representing 87% were fully answered and 
returned while 9 questionnaires representing 13% were not returned. The response rate was high and the findings 
were representative. 
 
4.3  Back ground Information Analysis 
The background information collected included the respondent’s position, level of education and years of 
experience. A pie chart was used to illustrate the study findings as shown in Table 4.2 below.  
Table 4.2 Background Analysis on respondent category 
Respondent Characteristics Characteristics Details Number of Respondents  Response Rate% 
Position Supply chain Manager 4 6 
Procurement Personnel 23 34 
Stores personnel 31 46 
Total   58 87% 
Cold chain logistics mainly involve the stores and procurement personnel with 46 % and 34% respondents 
respectively and 6% are their managers who oversee the cold chain operation .Below is a pie chart illustration. 
 
 
Figure 4.2 . Response Rate per Respondent Category 
The researcher also sought to find out the highest level of education attained by the respondents and 
also if they had any special training on Cold chain.  
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.5, No.9, 2015 
 
99 
Table 4.3 Background Analysis on Education Level 
Respondent 
Characteristics Characteristics Details Number  Respondents  Response Rate% 
Education level 1.Primary School 0 0 
2.Secondary school 9 13 
3.Certificate 15 22 
4.Diploma 16 24 
5.Graduate Degree 10 15 
6 Post graduate degree 8 12 
7.Others (special training on cold 
chain) 6 9 
Total   58 87% 
Results of the study indicated that 24% had a diploma, 22% a certificate, 15% had a degree and 12% 
had post graduate degrees. Out of all respondents only 9%   had a special training on cold chain. Education plays 
a very crucial role in the social-economic development and understanding and hence a high level of education 
depicts a higher and better understanding. In this case, majority of the respondents have diplomas and certificates 
and were able to respond accurately with understanding however the very low percentage of respondents 
specially trained in cold chain makes their competence in cold chain operations questionable. 
 
 
Figure 4.3 . Response per Educational level 
The researcher also sought the years of experience by respondents in cold chain process 
Table 4. 4 Background Analysis on Years of Experience 
Respondent 
Characteristics Characteristics Details Number of Respondents  Response Rate% 
Years of experience  1 11 16 
1-3 14 20 
3-5 23 34 
5-10 7 10 
 above 10 3 4 
Total   58 87% 
The results revealed 54% 16% and 10%, had worked at the organizations between, 1-5 years, less than 
1 year and 5-10 years respectively with only 4% with over 10 years experience . This indicates that majority of 
the employees have stayed in the organizations long enough to understand the routine and cold chain operations 
though not specially trained 
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Figure 4.4 . Response per years of experience 
 
4.4  Discussion of findings 
The findings which were presented in tables and percentage frequencies were discussed as follows. 
4. 4 .1 Storage conditions and facilities and Safety of vaccines. 
The responses were generated on a five point Likert scale; whereby the respondents were required to state their 
level of agreement where:   *SD=strongly disagree D=Disagree S=Satisfactory A=Agree SA=Strongly Agree 
f=Frequency    
Table 4.5  Storage conditions  
storage conditions and facilities   SD D S A SA 
Available special storage area F 0 9 12 31 6 
  % 0 16 21 53 10 
Enough storage space available F 4 6 24 18 6 
  % 7 10 41 31 10 
Fully functional storage equipment F 4 24 18 6 6 
  % 7 41 31 10 10 
Different storage equipment for different kinds of vaccines F 24 18 6 10 0 
  % 41 31 10 17 0 
Storage equipment are regularly checked for compliance F 30 18 10 0 0 
  % 52 31 17 0 0 
Existing SOPs that are followed to ensure proper storage F 24 18 6 6 4 
  % 41 31 10 10 7 
Measures in place to ensure vaccines don’t go bad F 0 0 20 24 14 
  % 0 0 34 41 24 
Storage practices are satisfactory F 10 18 20 3 7 
  % 17 31 34 5 12 
Average %   21 24 25 21 9 
The first objective of the study sought to determine how storage conditions influences safety of 
vaccines. Descriptive statistics in form of frequencies and percentages were used to summarize the findings as 
shown in Table 4.5. Craig, (2007) points that maintaining correct temperatures during storage are a very 
important task for cold chain items. A frequency of  53% of respondents agree that there exists special storage 
areas, 52% of respondents strongly disagree to regular checking of equipment for compliance.41% are satisfied 
with the storage space available and disagree on the functionality of equipments and availability of different for 
different kinds of vaccines. and 41% strongly disagree to the use of SOPs in storage of cold chain 
vaccines.However,34% are satisfied with the storage conditions and practices in their organisations.   
On average 25% of the respondents are satisfied with the storage conditions in their organisations 
while 24% disagree to having proper storage conditions for cold chain vaccines and only 9% strongly agree to 
having proper storage conditions that ensure safety of vaccines. 
This means that the storage conditions are not excellent to ensure safety of cold chain items. Control of 
storage conditions and temperature is essential in maintaining the quality of cold chain items and in helping to 
protect patients from sub-standard or ineffective medicines that may result from inadequate storage control 
(Blake, 2008). 
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4. 4 .2 Transport Systems and Safety of vaccines. 
The second objective of the study was to determine the influence of transport systems on the safety of vaccines 
in pharmaceutical distributor in Nairobi County. 
Table 4. 6   Transport Systems and Safety of vaccines 
Transport systems    SD D S A SA 
Special Vehicles for transportation of cold chain items F 30 18 10 0 0 
  % 52 31 17 0 0 
Enough vehicles to meet demand for distribution F 0 6 30 18 4 
  % 0 10 52 31 7 
Transport vehicles are fitted with functional temperature and 
humidity monitoring devices F 32 16 5 3 2 
  % 55 28 9 5 3 
Fleet system to manage distribution F 44 6 8 0 0 
  % 76 10 14 0 0 
Delivery is done within recommended timelines F 30 18 10 0 0 
  % 52 31 17 0 0 
SOPs are followed to ensure proper transport conditions F 24 18 6 6 4 
  % 41 31 10 10 7 
Transport and distribution practices are satisfactory F 10 18 20 3 7 
  % 17 31 34 5 12 
Average %   42 25 22 7 4 
*SD=strongly disagree D=Disagree S=Satisfactory A=Agree SA=Strongly Agree f=Frequency. 
The results on Table 4. 6 indicate that a frequency of 76% strongly disagree to having a fleet system 
that manages cold chain distribution, another 55% strongly disagree to the vehicles being fitted with functional 
temperature and humidity measuring devices and 52% of the respondents strongly disagree on the availability of 
special vehicles to transport cold chain items but are satisfied with the vehicles available to meet the 
demand .However, only 17% are satisfied with the deliveries being done within the recommended timelines and 
only 7% strongly agree to following transport SOPs while 5% of the respondents agree to having satisfactory 
cold chain transport systems. 
On average a majority of 42 % strongly disagree to having proper transport systems to ensure safety of 
cold chain items. This means that the safety of cold chain items is greatly compromised during transportation 
within the county because specialized vehicles should be used to transport cold chain products and be fitted with 
monitoring devices, temperature monitors depending on the size of the load (John, 2007). Refrigerated transport 
is also recommended for deliveries taking longer than three hours in transit provide assurance that temperatures 
in all parts of the load remain acceptable and hence vaccine potency maintained (Craig, 2007). 
4. 4 .3 Packaging and Safety of vaccines. 
The third objective was to evaluate the influence of Packaging on the safety of vaccines in pharmaceutical 
distributor in Nairobi County. 
Table 4. 7 Packaging  
Packaging    SD D S A SA 
Packaging SOPs exist for different cold items F 24 13 15 6 0 
  % 41 22 26 10 0 
Different packaging materials for different cold chain items F 0 11 20 22 5 
  % 0 19 34 38 9 
Protective gears to use during packaging F 0 12 31 9 6 
  % 0 21 53 16 10 
Customers are satisfied about the packaging F 0 15 13 18 12 
  % 0 26 22 31 21 
There are enough packaging equipment to meet demand F 4 6 24 15 9 
  % 7 10 41 26 16 
The packaging practices are satisfactory F 0 10 28 20 0 
  % 0 17 48 34 0 
Average %   8 19 38 26 9 
*SD=strongly disagree D=Disagree S=Satisfactory A=Agree SA=Strongly Agree f=Frequency. 
Descriptive statistics in form of frequencies and percentages were used to summarize the findings as shown in 
Table 4.7 above. 
A frequency of 53% of respondents is satisfied with the protective gears provided for use during 
packaging and 48% of the respondents are satisfied with the packaging practises in their organisations. However, 
41% of the respondents strongly disagree to existence of packaging SOPs for cold chain items but are satisfied 
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with the packaging equipments available and 34% of the respondents are satisfied with the availability of 
different packaging materials for different vaccines and 31% of the respondents agree that their customers are 
satisfied with their packaging practises.  
On average 38% of the respondents are satisfied with packaging practices for cold chain items and 
26% agree that packaging practises in their organisations ensure safe cold chain vaccines. However 8% of them 
disagree to having proper packaging practises mainly because they do not follow any SOPs for packaging of cold 
chain items. 
This means that proper packaging is key to ensuring delivery of safe cold chain vaccines according to 
Blanchard (2007), use of proper and recommended packaging material protects the cold chain items and ensures 
their safe delivery while use of correct protective gear protects the personnel doing the packaging of cold chain 
items. The study reveals that packaging procedures practised are satisfactory and delivery of safe vaccines is 
ensured. 
4. 4 .4 Technical Capacity and Safety of vaccines. 
The final objective of the study was to establish the extent to which technical capacity of pharmaceutical 
distributor companies in Nairobi County influences safety of vaccines. 
Table 4. 8  Technical Capacity  
Technical capacity   SD D S A SA 
Staff who handle cold chain items are specifically trained F 24 15 10 6 3 
  % 41 26 17 10 5 
Enough employees to handle the demand  F 4 6 24 15 9 
  % 7 10 41 26 16 
Equipment are regularly checked and serviced to avoid breakdown 
and ensure compliance F 30 18 10 0 0 
  % 52 31 17 0 0 
There are enough equipment to handle demand F 4 6 24 18 6 
  % 7 10 41 31 10 
There is a power backup to ensure constant power supply for 
equipment F 0 0 10 18 30 
  % 0 0 17 31 52 
Quality checks to ensure compliance with cold chain supply 
regulations F 36 18 4 0 0 
  % 62 31 7 0 0 
 
Average %   28 18 24 16 14 
*SD=strongly disagree D=Disagree S=Satisfactory A=Agree SA=Strongly Agree f=Frequency. 
 The results on table 4. 8  above reveal that 62% of respondents strongly disagree to having the 
technical capacity to perform quality checks on cold chain items in order to ensure compliance to supply chain 
regulations however, 52% of respondents strongly agree to availability of constant power to avoid any outages 
that may compromise tempreture conditions in freezers but strongly disagree to having their cold chain 
equipment checked and serviced to avoid breakdown . 41% of respondents have absolutely no special training in 
cold chain while only 15% agree to some form of training in cold chain supplies process. 
On average 28% of respondents strongly disagree to having adequate technical capacity to ensure 
safety of cold chain items in pharmaceutical distributor in Nairobi County while Only 14% strongly agree to 
having the technical capacity to handle cold chain items and ensure their safety. 
This means that most organizations are not technically capable to handle cold chain items and ensure 
their safety .Techinical capacity in terms of employee competence in  monitoring storage and transport 
conditions as well as handling of equipment and cold chain items during packaging is very important in ensuring 
vaccine safety (Estrada, F.2008) .Other technical issues like quality checks ,calibration of equipment, handling of 
the systems, correct documentation of the data, the correction of adverse events and the integration within 
standard operating procedures is a key issue which should not be underestimated for the safety of the cold chain 
supply products such as vaccines (Bishara, R.H. 2006) 
 
4. 5  Safety of vaccines 
The safety of vaccines was the dependent variable being measured. The researcher wanted to find out the general 
opinion of the respondents in regards to ensuring delivery of safe vaccines by their organisations. A frequency of 
62% a  strongly disagree to having any quality laboratory tests being performed on the cold chain items to 
confirm their potency, another  59% of the respondents  also strongly disagree to delivery of safe vaccines 
because the vaccines take longer than recommended time on transit and the recommended temperatures are 
neither monitored nor maintained as revealed by 34% of the respondents. Safety of cold chain vaccines seemed 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.5, No.9, 2015 
 
103 
to be compromised because 41% of the respondents strongly disagree to being specifically trained on cold chain 
and they do not use any S0Ps when handling cold chain vaccines. 
Table 4. 9  Safety of  cold chain items  
Safe cold chain items   SD D S A SA 
Cold chain items do not take longer than recommended time while 
on transit F 34 20 4 0 0 
  % 59 34 7 0 0 
Recommended temperatures are monitored and maintained while 
cold chain items are on transit F 19 20 13 6 0 
  % 33 34 22 10 0 
Only specifically recommended packaging materials are used for 
specific items. F 4 6 24 18 6 
  % 7 10 41 31 10 
SOPs are followed to the latter in ensuring that cold chain items 
maintain their integrity F 24 13 15 6 0 
  % 41 22 26 10 0 
Staff who handle cold chain items are specifically trained F 24 15 10 6 3 
  % 41 26 17 10 5 
Quality laboratory checks are performed to confirm potency of 
cold chain items. F 36 18 4 0 0 
  % 62 31 7 0 0 
Average %   41 26 20 10 3 
*SD=strongly disagree D=Disagree S=Satisfactory A=Agree SA=Strongly Agree f=Frequency. 
On average 41% strongly disagree to ensuring compliance and safety of vaccines while only  20% of the 
respondents are satisfied with the cold chain practices in their organizations to ensure safety of vaccines .3% of 
the respondents strongly agree to ensuring compliance and safety of cold chain vaccines in their organizations.  
This means that overall the safety of cold chain vaccines is compromised in most of our organizations and as 
Kamau and Mukui ,(2005), noted there is a lack of awareness by distributors on the sensitivity of cold chain 
items which  affects the products' therapeutic properties and consequently generate deficiency quality risks such 
as loss of therapeutic effects and intoxication with dire effects on the health of the users. Regulatory and 
compliance issues relating to transportation, storage, packaging and technical compliance , influences the safety 
cold chain items to the user level and are critical in this process to avoid degradation (Blake, 2008).  
 
4.6 Correlation Analysis 
 Correlation analysis was applied to determine the relationship between independent variables; Storage 
conditions, transport systems, packaging and technical capacity and dependent variable; Safety of vaccines. A 
range of +1 to -1 was used to determine the significance of the relationship between the independent and the 
dependent variables as either positive or negative in the cold chain pharmaceutical distributors in Nairobi County. 
The table below indicates the overall correlation between the variables. 




 Pearson Correlation Safety  of vaccines Storage conditions  Transport systems Packaging   Technical 
capacity 
Safety  of vaccines Rho 1     
  Sig. (2-tailed)      
  N 58     
Storage conditions Rho 0.463 1    
  Sig. (2-tailed) .000     
  N 58 58    
Transport systems  Rho 0.136 0.022 1   
  Sig. (2-tailed) 0.04 0.876    
  N 58 58 58   
Packaging   Rho 0.043 .331 -0.170 1  
  Sig. (2-tailed) 0.003 0.013 0.215   
 N 58 58 58 58  
technical capability Rho .0505 .0420 -.074 0.056                                         1 
  Sig. (2-tailed) .000 .774 .613       .361  





Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.5, No.9, 2015 
 
104 
Table 4.11 Correlation analysis on Storage conditions 
    Safety of vaccines Storage conditions 
Safety of Vaccines 
Pearson Correlation 1 0. 463 
Sig. (2-tailed)   0 .000 
N 58 58 
Correlation is significant at the 0.05 level (2-tailed). 
The results in Table 4.11 reveals a significant positive relationship of (r = 0. 463) between safety of 
vaccines and storage conditions in pharmaceutical distributors in Nairobi County. The study established that 
most pharmaceutical distributors have special storage facilities but are not upto the recommended standards by 
regulatory bodies to ensure that cold chain items and vaccines stored are safe for consumption (PPB,2013). 
Table 4.12 Correlation analysis on Transport systems 
    Safety of vaccines Transport systems 
Safety of Vaccines 
Pearson Correlation 1 0.136 
Sig. (2-tailed)   0.000 
N 58 58 
Correlation is significant at the 0.05 level (2-tailed). 
Table 4.12 shows a positive relationship of (r = 0. 136) between safety of vaccines and transport 
systems in pharmaceutical distributors in Nairobi County. This shows that safety of vaccines is not ensured in 
most pharmaceutical distributors and hence the weak relationship mostly because most transport systems are not 
specialised for cold chain items and do not have the temperature monitoring devices.  
Table 4.13 Correlation analysis on Packaging 
    Safety of vaccines  Packaging  
Safety of Vaccines 
Pearson Correlation 1 0.043 
Sig. (2-tailed)   0.003 
N 58 58 
Correlation is significant at the 0.05 level (2-tailed). 
A positive relationship of (r = 0. 043) is shown between Packaging and safety of vaccines in 
pharmaceutical distributors in Nairobi County. This shows that packaging of cold chain items is not upto 
standard to ensure that safety of vaccines is ensured .This is mainly attributed to the fact that SOP’S are not 
followed during packaging.  
Table 4.14 Correlation analysis on Technical capacity 
    Safety of vaccines Technical Capacity 
Safety of Vaccines 
Pearson Correlation 1 
 
 0.505 
Sig. (2-tailed)    0.000 
N 58 58 
Correlation is significant at the 0.05 level (2-tailed). 
A significant positive relationship of (r = 0. 505) exists between safety of vaccines and technical 
capacity of most in pharmaceutical distributors in Nairobi County. The study established that most 
pharmaceutical distributors do not have the technical capacity to handle cold chain items since most of them do 
not have the special training in cold chain and neither are equipments checked for compliance nor quality checks 
done to ensure safety of vaccines. 
 
4.7 Correlations summary 
Table 4.15 Correlations summary 
 R R2(Coefficient of determination % coefficient of determination 
Storage Conditions 0.463 0.214 21.0 
Transport Systems  0.136 0.018 1.8 
Packaging 0.043 0.002 0.2 
Technical Capacity  0.505 0.255 25.5 
TOTAL 48.5 
The results of Table 4.11 above show that safety of vaccines in pharmaceutical distributors in Nairobi 
County is attributed to 21% proper storage conditions,1.8% to Transport Systems which is very low as well as 
0.2% to packaging and a larger percent of 25% of safety of vaccines is attributed to technical capacity .However, 
all these variables contribute to only 48.5%  of the safety of vaccines while 51.5% of vaccine safety is influenced 
by other factors. The other factors that influence safety of vaccines are prevailing conditions during custom 
clearance which could be exposure to extreme temperatures, poor handling and storage (Kamau & Mukui ,2005). 
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Safety of cold chain items is very critical and a 48.5%   safety is not safe enough as it compromises the effects 
they could have on the consumers. Bishara, (2007) asserts that pharmaceutical cold chain items like vaccines are 
particularly sensitive materials which, if not manufactured, shipped, stored, packaged and handled under 
stringent controls, can become ineffective or even hazardous to the consumer due to reduced potency.     
 
5. SUMMARY, CONCLUSION AND RECOMMENDATIONS 
5.1 Introduction 
This chapter presents the summary of the research findings on the Influence of cold chain supply logistics on 
supply of safe cold chain pharmaceuticals.  The chapter details the summary of the findings, conclusion, 
recommendation and suggestion for further studies. This chapter presents the summary of findings, conclusion 
and recommendations of the study. In order to rationalize the findings of the study, the chapter also discusses the 
findings in the light of secondary literature review from the organisations records and relate it to previous studies 
done on cold chain and from the current research. 
 
5.2 Summary of the Research Findings 
The main objective of the research therefore was to study the influence of cold chain supply logistics on the 
safety of vaccines. A sample of 67 respondents was selected from the target population with similar 
characteristics; out of the 67 issued questionnaires 58 were filled and returned. A combination of descriptive 
statistics and inferential statistics were used to analyze the data.  
5.2.1 Storage conditions 
In this study, a number of objectives were set to be achieved. The first objective was to establish the influence of 
storage conditions of cold chain items on delivery of safe vaccines. Regarding this, it was established that upto 
52% of respondents conformed there is poor validation and qualification of storage facilities and monitoring 
devices. There are no different storage equipment for different vaccines in upto 41% of the organizations and 
hence run a risk of cross contamination and temperature excursions during storage which compromises the 
quality of vaccine. The research confirmed that validated systems with respect to calibration of storage facilities 
temperature probes and sensors and thermometers are generally poor along the supply chain with only 34% 
having satisfactory practices.  
5.2.2 Transport systems 
The second objective was to establish the influence of transport systems on safety of vaccines. The research 
confirmed that upto 76% of the firms do not have a fleet system that helps manage the distribution of cold chain 
vaccines .Calibration and qualification of transportation vans and carrier boxes are generally poor along the 
supply chain, and specialized vehicles for transport of cold chain items do not even exist in 52% of the firms and 
this compromise the safety of cold chain items. There are no procedures in place to verify actual temperature of 
cold chain medicines before taking delivery or dispatch to retail facilities and transport of vaccines does not 
always happen within the recommended timelines which exposes them to tempreture excursions and their safety 
compromised. 
5.2.3 Packaging  
Evaluation of the influence of Packaging in pharmaceutical distributors in Nairobi on the safety of vaccines was 
the third objective of the study and the research findings reveal that in as much as upto 41% of organisations do 
not follow packaging SOPs .The organisations packaging practices are satisfactory according to 48% of 
respondents. However, packaging practices still have to be improved and different packaging materials used for 
different vaccines and SOPs followed in order to avoid any compromise on the safety of cold chain items and 
raise the percentage of satisfactory practice to upto 75% and above to increase the confidence in delivery of safe 
cold chain vaccines. 
5.2.4 Technical Capacity 
The final objective of the study was to establish the extent to which technical capacity in pharmaceutical 
distributors in Nairobi influence safety of Vaccines. The findings of the study reveal that no quality checks are 
performed on the vaccines to confirm viability in 62% of the firms which means that the viability of the vaccines 
delivered is not confirmed . The firms technical capacity does not guarantee delivery of safe cold chain 
pharmaceuticals  mainly because most equipment used in handling cold chain items are not regularly checked 
and serviced according to 52% of the respondents, hence not technically compliant..  Most employees handling 
cold chain items are not specifically trained with only 15% agreeing to some form of training or coaching and 
this greatly compromises the safety of the vaccines in as much as there are sufficient equipment and there is 




The overall finding of this study is that control of storage and transportation temperature, having proper storage 
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conditions, packaging materials and technical competence is essential in maintaining the quality of cold chain 
pharmaceuticals and hence delivery of safe cold chain pharmaceuticals.  The study findings reveal that cold 
chain supply logistics are poorly coordinated and not fully adhered to and hence have a negative  influence on 
the safety of vaccines among other cold chain pharmaceutical items .This means that  end users are exposed to 
sub-standard or ineffective vaccines and pharmaceuticals that may result from poorly coordinated cold chain 
supply logistics. In view of this, more effort should be made to provide proper cold chain logistics management 
for temperature sensitive pharmaceuticals to ensure that the quality and efficacy of the product are not 
compromised along the supply chain.  
 
5.4 Recommendations 
Relevant recommendations were made considering the findings of the study which  if adopted would lead to 
efficient and effective cold chain supply logistics  in order to ensure product  safety  in terms of  quality, potency 
and efficacy and hence guarantee public health and safety.  
5.4.1 Storage Conditions 
Storage conditions for cold chain items need to be closely monitored and improved  so that the safety of cold 
chain items is guaranteed in having fully functional and enough storage facilities for different cold chain items 
because the research findings indicate that safety of cold chain items is greatly compromised in the current 
situation. Validation of storage facilities need to be done on a regular basis and storage temperatures checked 
(Bishara R.H, 2006). More storage freezers of varying temperature ranges need be purchased since all the cold 
chain items are not stored at the same temperatures. In view of this, proper pharmaceutical refrigerators are 
recommended for the storage of cold chain products. Additionally, cold rooms, refrigerators and carrier boxes 
should be qualified by Kenya Bureau of Standards to ensure capacity to maintain the required temperature 
during storage. 
5.4.2 Transport Systems 
The transport systems for cold chain items need to be improved put and have a fleet management system for the 
same so that the safety of cold chain items is guaranteed in having fully functional and enough vehicles for 
transport of cold chain items. Temperature validation should be ensured by having special vehicles bought and 
fitted with the correct temperature controlling and monitoring gadgets for cold chain transport. 
This is because the air within this special cold chain transport and storage equipment is circulated by a 
fan, which provides a uniform temperature profile and a rapid temperature pull down after the door has been 
opened with alarm systems to draw attention when there is temperature excursion (Blanchard, D. 2007).  
All temperature probes (for cold chain mapping), sensors and thermometers must be calibrated and 
regularly maintained to the required standards within the travel range respectively.       
5.4.3 Packaging 
Packaging SOP’S need to be updated and followed strictly and this therefore means that different packaging 
materials for different cold chain items need to be purchased. The exposure time during break bulk in packaging 
should be reduced by having proper equipment and protective gears for handling (Cleland,A.C,2005). It is 
recommended that the organization use refrigerated packaging systems such as use of dry ice, gel pack, 
kryotrans, kodiak, styrofoam  and envirotainers to keep the cold chain products safe and in good condition when 
packed. 
5.4.4 Technical capacity   
The firm’s technical capacity does not guarantee delivery of safe cold chain pharmaceuticals.  This is because 
equipments are not technically compliant and also no quality checks are performed on the vaccines to confirm 
viability. This therefore suggests that special training is required for all personnel involved in cold chain 
sensitivity of cold chain items and hence improve their understanding and competency in handling cold chain 
pharmaceuticals to ensure their safety.  
All equipment also need to be properly calibrated and up to standard as recommended by regulatory 
bodies. SOPs in place should be updated and strictly followed since; one of the challenges identified was the 
poor adherence and implementation. WHO cold chain management systems (GDP, GSP, etc) could also be 
adopted in order to adhere to some standard as recommended by regulatory bodies. 
 
5.5 Suggestions for Future Study 
Future studies could   research on establishing the extent to which the identified logistics challenges affect cold 
chain pharmaceuticals potency, efficacy and quality by performing quality laboratory checks in Nairobi 
County .This can be achieved by sampling from known batches of cold chain pharmaceuticals with evidence and 
documentation that it has been distributed along the supply chain (whole, retail and end user) for traceability and 
be subjected to laboratory analysis. 
Following the analysis of secondary data from the forms records , it was noted that there are other 
factors that influence delivery of safe cold chain pharmaceuticals like Coordinated customs clearance and  
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information technology which is an area of study that could reveal a lot in Cold chain studies. 
Finally the role of regulatory authorities in enforcing regulatory standards to ensure compliance by 
cold chain pharmaceutical distributors engaged in cold chain medicines as a business is an area that needs to be 
explored further given that the research findings indicate very poor compliance to SOPs . 
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